We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

70 hedge funds and large institutions have $216M invested in ChemoCentryx, Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

8% more capital invested

Capital invested by funds: $200M → $216M (+$15.8M)

6% more call options, than puts

Call options by funds: $721K | Put options by funds: $680K

0% more funds holding

Funds holding: 7070 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
70
Holders Change
Holders Change %
0%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
27
Reduced
22
Closed
7
Calls
$721K
Puts
$680K
Net Calls
+$41K
Net Calls Change
+$9K
Name Holding Trade Value Shares
Change
Change in
Stake
Ohio Public Employees Retirement System (OPERS)
26
Ohio Public Employees Retirement System (OPERS)
Ohio
$616K
Millennium Management
27
Millennium Management
New York
$594K -$409K -51,507 -42%
BPC
28
Banque Pictet & Cie
Switzerland
$592K
RA
29
Royce & Associates
New York
$576K
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$517K
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$420K +$4.96K +624 +1%
CS
32
Credit Suisse
Switzerland
$413K +$184K +23,192 +86%
BCM
33
Bridgeway Capital Management
Texas
$412K
BBA
34
Baker Bros. Advisors
New York
$404K
Morgan Stanley
35
Morgan Stanley
New York
$344K +$126K +15,914 +61%
Deutsche Bank
36
Deutsche Bank
Germany
$342K +$326K +41,100 +6,412%
TA
37
Teachers Advisors
New York
$336K +$2.82K +355 +0.9%
EGA
38
Eagle Global Advisors
Texas
$328K +$127K +15,942 +67%
ProShare Advisors
39
ProShare Advisors
Maryland
$316K -$14K -1,758 -4%
KeyBank National Association
40
KeyBank National Association
Ohio
$316K
Charles Schwab
41
Charles Schwab
California
$289K
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$254K +$245K +30,840 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$211K -$96.2K -12,115 -32%
DekaBank Deutsche Girozentrale
44
DekaBank Deutsche Girozentrale
Germany
$173K +$3.97K +500 +2%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$156K -$35.4K -4,454 -19%
NFA
46
Nationwide Fund Advisors
Ohio
$154K -$11.1K -1,392 -7%
AIG
47
American International Group
New York
$135K -$6.4K -806 -5%
Wells Fargo
48
Wells Fargo
California
$126K +$110K +13,832 +930%
BA
49
BlackRock Advisors
Delaware
$121K +$11.9K +1,495 +11%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$112K +$108K +13,622 New

CCXI Hedge Fund Activity: Q2 2015 in Review

70 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2015, worth a combined $216M — up 7.9% from $200M a quarter earlier.

Fund positioning in CCXI was balanced in Q2 2015: 7 funds opened new positions, 7 closed out, 27 added to existing stakes and 22 trimmed.

The largest buyer was Redmile Group, adding an estimated $3.64M. The largest seller was BVF Inc, cutting an estimated $8.21M.

  • 70 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $216M of ChemoCentryx, Inc. stock for Q2 2015, up 7.9% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx, Inc. positions in Q2 2015 and 7 closed out, a net change of 0 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2015 was Redmile Group, an estimated $3.64M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2015 was BVF Inc, an estimated $8.21M sold.

Based on aggregated 13F filings for Q2 2015.